Top 5 HealthTech Startups in Australia: 2023

Best 5 HealthTech Startups in Australia: 2023 | The Lifesciences Magazine

HealthTech Startups in Australia and innovative businesses in the healthcare industry are using technology to completely reimagine the medical field for the sake of patients, doctors, and scientists alike. Everyone benefits from this new turn of events. Blockchain, AI, big data analysis, and internet-connected medical devices are just a few examples of technological advances that play an important role in the field of medicine.

New businesses have arisen to capitalize on the growing emphasis on the use of technology in HealthTech Startups in Australia. A number of these new firms have developed innovative methods for diagnosing and treating patients, expanded the range of accessible treatment options at more affordable costs, and sped up the process of medication discovery and development.

Here are the Best 5 HealthTech Startups in Australia: 2023

1. KiviHealth (Kivi)

KiviHealth is a HealthTech Startups in Australia in the field of health technology with the goal of developing a digital health information management system that is both patient-centric and affordable. This system is intended for use in a variety of healthcare settings, including hospitals, clinics, pharmacies, and laboratories.

Best 5 HealthTech Startups in Australia: 2023 | The Lifesciences Magazine

• Established in 2015 • Bhanu Mahajan and Rajandeep Singh were the company’s founders • Delhi is where its headquarters are located

• Finance: The company has gotten 183,000 dollars in angel funding

2. Lybrate

Lybrate is a business that is working to improve the quality of healthcare in India by making it easier for patients to locate highly qualified medical professionals in their immediate vicinity. HealthTech Startups in Australia, Patients are able to search for physicians based on their region and area of expertise, and they are also able to make appointments with recognized medical professionals.

Best 5 HealthTech Startups in Australia: 2023 | The Lifesciences Magazine

• Founded in the year 2013 • Saurabh Arora was the one who initiated the company’s creation.

• Headquarters located in Delhi • Funding: Million Venture Capital has provided the company with $14.3 Million in donations

3. Eucalyptus

HealthTech Startups in Australia In 2019, Alexey Mitko, Benny Kleist, Charlie Garside, and Tim Doyle established the basis for what would eventually become Eucalyptus. [citation needed] The company known as Eucalyptus, which specializes in medical technology, is the one that is in charge of developing patients’ digital experiences.

The company’s four distinct healthcare brands function as the connecting link between telemedicine consultations with doctors, pharmacy delivery, and ongoing patient care. Both NewView Ventures and W23 are considered to be the company’s most influential investors.

4. The Global Kinetics Corporation (GKC)

Malcolm Horne initiated the establishment of Global Kinetics in the year 2007. Through the development of innovative medical technology, Global Kinetics Pty Ltd (GK) is dedicated to enhancing the quality of life of those living with Parkinson’s disease and other movement disorders.

Best 5 HealthTech Startups in Australia: 2023 | The Lifesciences Magazine

GK is well on its way to achieving its goal of revolutionizing the treatment of Parkinson’s disease. This will be accomplished by enabling informed treatment decisions that are based on continuous and objective measurement of patients’ key movement symptoms while they are in their natural environments.

5. Botanix Pharmaceuticals

Botanix Pharmaceuticals is a clinical-stage dermatological firm that is developing innovative therapies for common skin illnesses and infections by using their revolutionary delivery technology, which is known as PermetrexTM. HealthTech Startups in Australia, have been successful in luring a team of world-class professionals and considerable financial backing to assist in the development of our goods.

They are making rapid progress, but it will never come at the price of their unwavering dedication to doing research and development (R&D) in an ethical manner and according to the highest clinical standards required by the Food and Drug Administration of the United States (FDA). Using an evidence-first strategy, they want to accomplish their mission of revealing the full potential of synthetic cannabinoids for the benefit of people all around the globe.

Share Now